Apparently, over 19,000 people believe it. Last week, the Endeleo Institute hosted a luncheon event in partnership with the RUSH Alzheimer’s Disease Center to thank older adult participants engaged in the ASPREE (ASPrin in Reducing Events in the Elderly) study.
Due to the global burden associated with age-related diseases, cost-effective strategies to maintain healthy active lifestyles in aging populations are in dire need. There is evidence that low dose aspirin may be effective in primary prevention against a broad spectrum of diseases prevalent in the aged such as :
-
Stroke
-
Cancer
-
Dementia
The ASPREE study will examine whether the potential primary prevention benefits of low dose aspirin outweigh the risks in older healthy individuals. The group photo contains local members of the U.S. study and includes Trinity members. We highlight this event because there is strong need for people from our community to participate in more clinical trials for diseases that disproportionately affect us, like Alzheimer’s and Dementia.
If you are 65 or older and interested in more information regarding how you can participate in helping to become part of the solution to the diseases that plague our families, please contact us at 773-966-1590.
Get in the picture.
